Clinical Trial Update: Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating sacituzumab govitecan in combination with talazoparib for metastatic breast cancer; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)
• Talazoparib (talazoparib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING